Buy and Bill Use Continues to Decrease

$0.00

Buy and Bill Use Continues to Decreases. Understanding provider-administered drug reimbursement is an ongoing challenge for industry stakeholders. Providers, patients and payers face issues that need to be addressed by companies launching or selling products into this market.